SECTIONS & SUB-SECTIONS TITLE RATIONALE TIMELINES COMPLETED

Similar documents
PHARMACY SERVICES / MEDICATION USE

Compounded Sterile Preparations Pharmacy Content Outline May 2018

Implementing USP

USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD

MODEL STANDARDS FOR PHARMACY COMPOUNDING OF NON-HAZARDOUS STERILE PREPARATIONS

The Joint Commission Medication Compounding Certification (MDC) FAQs

Pharmacy Sterile Compounding Areas

Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS

Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS

Clinical IQ, LLC September 2, 2009

Sterile Compounding of Hazardous Drugs

6/23/2011. Compounded Sterile Products Update and Review. Learning Goals for the Pharmacist. Learning Goals for the Pharmacy Technician

Aseptic Processing Assessments

Guidance for registered pharmacies preparing unlicensed medicines

Advanced Sterile Product Preparation Training and Certificate Program

SFHPHARM11 - SQA Unit Code FA2X 04 Prepare extemporaneous medicines for individual use

EHR] A INSPECTION REPORT. Guy s Hospital Pharmacy St Thomas Street London SE1 9RT. Safeguarding public health

CHAPTER 17 STERILE PRODUCT COMPOUNDING 17-1

The Home Infusion Compounder's Guide to the Second Proposed Revision to USP <797>

CASE STUDY: PENINSULA REGIONAL MEDICAL CENTER

Accreditation Commission for Health Care

STANDARDS Point-of-Care Testing

11/4/2016. Sterile Compounding: USP<797> Revisions and the Compounding Quality Act. In the 1930 s and 40 s, 60% of all medications were compounded.

CHAPTER 2 GENERAL PRACTICE OF PHARMACY REGULATIONS. These regulations are promulgated as authorized by the Act.

KPIC Aseptic Technique Training Program

KPIC Aseptic Technique Training Program Friday, August 24 th Saturday, August 25 th, 2018

To provide information about the role of the pharmacy in Infection Prevention and Control.

Department Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual

USP <797> PERSONAL HYGEINE PERSONAL PROTECTION EQUIPMENT

Newfoundland and Labrador Pharmacy Board Standards of Practice

C DRUG DISTRIBUTION SYSTEMS

Hospital and Other Healthcare Facilities

TOPIC 1 ROLES & RESPONSIBILITIES

Laboratory Chemical Hygiene Plan Research Lab

National Association of Rural Health Clinics

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER STERILE PRODUCT PREPARATION IN PHARMACY PRACTICE TABLE OF CONTENTS

Arizona Department of Health Services Licensing and CMS Deficient Practices

STATE OF FLORIDA DEPARTMENT OF HEALTH

An Overview of Sterile Compounding. Marshall Moleschi, Registrar Ontario College of Pharmacists

D DRUG DISTRIBUTION SYSTEMS

NJ Dept of Health Central Service Standards SUBCHAPTER 8. CENTRAL SERVICE. 8:43G-8.1 Central service policies and procedures

Australian/New Zealand Standard

Laboratory Chemical Hygiene Plan -- Teaching Lab

Intravenous Admixture Program. Effective Date: 3/4/95. Revised: 04/08, 7/11, 7/14. Page 1 of 17. Purpose:

Management Standards. EHS Policy and Program

SECTION HOSPITALS: OTHER HEALTH FACILITIES

1.0 Sterile Compounding Personnel

NON-STERILE PREPARATIONS

NORTH DAKOTA STATE BOARD OF PHARMACY PRACTICE ACT PAGE #

25-03 Verbal/Telephone Orders Procedure on recording verbal order was updated to reflect current procedure.

Worksheet: Friend, Foe or Both?

Bed Rail & Inspection Policy and Procedure Checklist

Radiopharmaceutical. Qualification. Checklist

STATE OF FLORIDA DEPARTMENT OF HEALTH

November 17, Ontario College of Pharmacists Re: Open Consultation Feedback 483 Huron Street

Pulmonary Care Services

Section 5: Premises, Equipment and Storage

Responding to Infection Prevention and Control (IPAC) Complaints. Monali Varia, MHSc, CIC Peel Public Health November 29, 2017

San Francisco General Hospital INFECTION CONTROL

Infection Prevention Checklist Section I: Policies and Practices I.1 Administrative Measures

Understanding USP 797

PACKAGING, STORAGE, INFECTION CONTROL AND ACCOUNTABILITY (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

NBCP PO C Administration of injections

Objectives Top Ten Cited Deficiencies for Acute Care Facilities April 21, 2015

Meeting New Requirements for Sterile Compounding Webinar

REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY

PPLGS SQA Code HD4V 04 Maintain food safety when storing, holding and serving food

Definitions: In this chapter, unless the context or subject matter otherwise requires:

GENERAL MEDICATION SECURITY MEDICATION STORAGE HOSPITAL ASSESSMENT CRITERIA CATEGORIES

DETAILED INSPECTION CHECKLIST

The Joint Commission

Level 3 Award in Supervising Food Safety in Catering

Systemic anti-cancer therapy Care Pathway

Infection Control Checklist for Dental Settings Using Mobile Vans or Portable Dental Equipment. Guiding Principles of Infection Control:

USP <797> does not apply to the administration of medications.

Texas Administrative Code

Preventing Occupational Exposure to Hazardous Drugs

ONCOLOGY PRACTICE MANAGEMENT

Clean and store care equipment to minimise the risks of spreading infection

Burn Intensive Care Unit

7 th Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration

TRAINING CALENDAR MARCH 2018

Pharmacy General Personnel

Ministry of Labour Occupational Health & Safety and Infection Prevention & Control

ASHP Guidelines on Compounding Sterile Preparations

A Game Plan to Surviving a Joint Commission Survey. May Adra, BS Pharm, PharmD, BCPS

2018 Pharmacy Education Series

Practice Tools for Safe Drug Therapy

Storage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431

BASINGSTOKE AND NORTH HAMPSHIRE HOSPITALS NHS FOUNDATION TRUST

Overview. PPLHSL30 - SQA Unit Code HK6M 04. Ensure food safety practices are followed in the preparation and serving of food and drink

Observations will be made of the storage. knowledge of the hazardous materials. labeling the container to the use of. containers (which may range from

STATE OF FLORIDA DEPARTMENT OF HEALTH

Health & Safety Policy and Procedures Manual SECTION 31 CADMIUM

Health and Safety in the lab. Seyed Hosseini SA Pathology Chemical Pathology

The Royal Society for the Promotion of Health. Level 3 Award in Supervising Food Safety in Catering

Ensuring Healthcare Worker Safety When Handling Hazardous Drugs: The Joint Position Statement From the Oncology Nursing Society, the American

JOB DESCRIPTION. SENIOR PHARMACY ASSISTANT TECHNICAL OFFICER Aseptic Services

Level 2 Certificate in Pharmaceutical Science ( )

Clinical staff undertaking Endoscopy and Nasendoscope interventions

Transcription:

Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations Schedule of Implementation (Note: New Sterile Compounding Sites are expected to be compliant immediately with all Model Standards requirements) SECTIONS & SUB-SECTIONS TITLE RATIONALE TIMELINES COMPLETED 1 2 3 INTRODUCTION OBJECTIVES REGULATORY FRAMEWORK Needs to become familiar with the framework 4 ABBREVIATIONS 5 CORE REQUIREMENTS FOR A STERILE COMPOUNDING SERVICE Personnel needs to understand their role and responsibilities 5.1 Personnel 5.1.1 Roles and responsibilities 5.1.1.1 Pharmacy manager or pharmacy department head 5.1.1.2 Sterile compounding supervisor 5.1.1.3 Compounding personnel 5.1.2 Training and assessment All personnel 5.1.2.1 Conditions 5.1.2.2 Initial training and assessment program 5.1.2.3 Competency assessment program 5.1.2.4 Management of the competency assessment program involved will have received training 5.2 POLICIES AND PROCEDURES Policies and procedures need to be prepared and made available to all personnel for training Within 6 months for the establishment of the competency program Within 6 months full implementation Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations Schedule of Implementation New Brunswick College of Pharmacists 1

5.3 FACILITIES AND EQUIPMENT Developmental and planning begin immediately. Longer period for allowing acquisition of equipment. and if there are changes/upgrades required an action plan must be prepared to show a full implementation within a 2-year frame 5.3.1 Useful references To become familiar immediately with references 5.3.1.1 ISO Standard 14644-1 To become familiar immediately with references 5.3.2 Facilities reserved for the compounding of non-hazardous sterile preparations Developmental and planning begin immediately. Longer period for 5.3.2.1 Dimensions 5.3.2.2 Lighting 5.3.2.3 Heating, ventilation and air conditioning systems for controlled rooms (clean room and anteroom) allowing acquisition 5.3.2.4 Windows and openings of equipment. 5.3.2.5 Compounding areas 5.3.2.6 Shared facilities 5.3.2.7 All other facilities 5.3.2.8 Materials and finishes 5.3.2.9 Accessories 5.3.2.10 Work surfaces and furniture 5.3.2.11 Signage 5.3.2.12 Facility Maintenance 5.3.3 Equipment Required for sterile compounding 5.3.3.1 Primary Engineering Control Required for sterile compounding and if there are changes/upgrades required an action plan must be prepared to show a full implementation within a 2-year frame Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations Schedule of Implementation New Brunswick College of Pharmacists 2

5.3.3.2 Other devices, instruments or accessories related to the compounding of non- Required for sterile hazardous sterile preparations compounding 5.3.3.3 Personal protective equipment and clothing Personnel needs to be appropriately garbed and gloved 5.3.4 Cleaning and disinfecting in areas reserved for the compounding of non-hazardous Cleaning and sterile preparations disinfection need to 5.3.4.1 General be appropriately 5.3.4.2 Disinfectant performed 5.3.4.3 Equipment used for cleaning and disinfection and its storage 5.3.4.4 Garbing of cleaning and disinfecting personnel (housekeeping personnel) 5.3.4.5 Cleaning frequency 5.4 GENERAL MAINTENANCE LOG 6 PRODUCT AND PREPARATION REQUIREMENTS BUD established in accordance with Model Standards requirements 6.1 Beyond-use date and dating methods 6.1.1 Beyond-use date for preparations 6.1.2 Beyond-use dates for commercially available products according to type of container (single-dose vial or multiple-dose container) 6.1.2.1 Single-dose vial 6.1.2.2 Open ampoule 6.1.2.3 Multi-dose container (ex. Vials) 6.1.3 Beyond-use date according to risk of microbial contamination 6.1.4 Beyond-use dates for immediate-use preparations 6.1.5 Beyond-use dates of 12 hours or less for preparations compounded in segregated 6.2 Compounded sterile preparation protocols Documentation needs to be in line with Model Standards requirements 6.3 Compounded sterile preparation log Documentation 6.3.1 6.3.2 Compounded sterile preparation log for one patient (individual preparations) Compounded sterile preparation log for preparations prepared in batches needs to be in line with Model Standards Full implementation within 6 months and if there are changes/upgrades required an action plan must be prepared to show a full implementation within a 2-year frame Within 6 months Within 6 months Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations Schedule of Implementation New Brunswick College of Pharmacists 3

requirements 6.4 Patient file 6.5 Conduct of personnel in areas reserved for the compounding of sterile preparations Personnel will have appropriate 6.5.1 Conditions that may affect preparation quality conduct 6.5.2 Conduct before entering the anteroom 6.5.3 Conduct in controlled areas (clean room and anteroom) 6.6 Aseptic compounding of non-hazardous sterile preparations Adherence to 6.6.1 General 6.6.2 Hand and forearm hygiene and garbing 6.6.2.1 Hand and forearm hygiene 6.6.2.2 Garbing 6.6.3 Introducing products and equipment into the clean room 6.6.4 Cleaning and disinfecting the primary engineering control (PEC) 6.6.5 Aseptic technique for compounding sterile preparations 6.6.6 Verification of final compounded sterile preparations 6.6.6.1 Role of personnel in verification 6.6.6.2 Process for verification 6.6.6.3 Verification by image capture or live camera 6.6.6.4 Verification not required 6.6.6.5 Second verification 6.6.7 Labelling of final compounded sterile preparations 6.6.7.1 General 6.6.7.2 Label and insert aseptic technique is essential 6.7 Packaging Within 6 months 6.7.1 Packaging process 6.7.2 Packaging procedure 6.8 Storage Within 6 months 6.9 Transport and delivery of compounded sterile preparations Within 6 months 6.10 Recall of sterile products or final compounded sterile preparation Within 6 months 6.11 Incident and accident management Within 6 months Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations Schedule of Implementation New Brunswick College of Pharmacists 4

6.12 Waste management Within 6 months 7 QUALITY ASSURANCE PROGRAM A longer period with 7.1 Program content may be required to full implementation 7.2 Results and action levels develop and in a 2-year period 7.3 Verification of equipment and facilities implement appropriate 7.3.1 Verification of equipment supporting compounding activities program 7.3.1.1 Certification 7.3.1.2 Temperature readings 7.3.2 Verification of controlled rooms and the primary engineering control (PEC) 7.3.2.1 Certification 7.3.2.2 Certificate provided by manufacturer (in factory) 7.3.2.3 Environmental verification 7.4 Quality assurance of personnel involved in aseptic compounding 7.4.1 Gloved fingertip sampling (GFS) 7.4.2 Media fill test 7.5 Quality assurance of compounded sterile preparations Within 6 months 7.6 Documentation of quality control activities Within 6 months 8 SOURCE FOR ADDITIONAL INFORMATION 9 GLOSSARY 10 LIST OF TABLES 11 APPENDICES POLICIES AND PROCEDURES FOR THE COMPOUNDING OF NON-HAZARDOUS 1 2 STERILE PREPARATIONS MANDATORY AND SUPPLEMENTAL REFERENCES Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations Schedule of Implementation New Brunswick College of Pharmacists 5

3 TRAINING OF COMPOUNDING PERSONNEL AND CLEANING AND DISINFECTING PERSONNEL PROCEDURE TEMPLATE 4 MINIMUM INDICATORS FOR CERTIFICATION OF CONTROLLED AREAS AND 5 PRIMARY ENGINEERING CONTROL CERTIFICATION OF CONTROLLED AREAS, LAMINAR AIRFLOW WORKBENCHES AND 6 BIOLOGICAL SAFETY CABINETS TEMPLATE FOR THE DRAFTING OF COMPOUNDING PROTOCOLS TO BE 7 COMPLETED FOR EACH DRUG EXAMPLES OF STERILE PREPARATIONS THAT MUST BE VERIFIED AT EACH STAGE OF 8 COMPOUNDING EXAMPLES OF STERILE PREPARATIONS THAT DO NOT REQUIRE VERIFICATION 9 DURING THE COMPOUNDING PROCESS TEMPERATURES FOR DIFFERENT TYPES OF STORAGE 10 INCIDENT/ACCIDENT REPORTING AND FOLLOW-UP FORM 11 COMPONENTS OF A QUALITY ASSURANCE PROGRAM 12 12. BIBLIOGRAPHY Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations Schedule of Implementation New Brunswick College of Pharmacists 6